Wuppertal, Germany

Nicole Petesch

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicole Petesch: Innovator in Immunoassay Technology

Introduction

Nicole Petesch is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of immunoassays, particularly with her innovative approach to calibrators used in these tests. Her work is instrumental in enhancing the accuracy and reliability of diagnostic procedures.

Latest Patents

Nicole holds a patent for a "Tropinin I calibrator and method of use thereof in a sandwich immunoassay." This invention involves a conjugate that consists of a sequence of the analyte and an antibody against one of the antibodies used in the test. It can be employed in aqueous solution and in precisely known quantity as a stable calibrator in a sandwich immunoassay for detecting the analyte. This advancement is crucial for improving diagnostic accuracy in clinical settings.

Career Highlights

Nicole Petesch is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. Her role at Bayer has allowed her to work on cutting-edge research and development projects that push the boundaries of medical diagnostics.

Collaborations

Throughout her career, Nicole has collaborated with esteemed colleagues such as Christoph Petry and Margit Doth. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Nicole Petesch's contributions to immunoassay technology exemplify her dedication to advancing medical diagnostics. Her innovative patent and collaborative efforts highlight her role as a key figure in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…